TWA
SUPN icon

TCI Wealth Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

TCI Wealth Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-233
Closed -$8.44K – 1998
2023
Q1 		$8.44K Hold
233
– – ﹤0.01% 1191
2022
Q4 		$8.31K Hold
233
– – ﹤0.01% 1201
2022
Q3 		$8K Hold
233
– – ﹤0.01% 1189
2022
Q2 		$7K Buy
233
+3
+1% +$86 ﹤0.01% 1288
2022
Q1 		$7K Hold
230
– – ﹤0.01% 1353
2021
Q4 		$7K Buy
230
+11
+5% +$334 ﹤0.01% 1462
2021
Q3 		$6K Buy
219
+38
+21% +$1.02K ﹤0.01% 1512
2021
Q2 		$6K Buy
181
+11
+6% +$337 ﹤0.01% 1362
2021
Q1 		$4K Buy
170
+73
+75% +$2.04K ﹤0.01% 1422
2020
Q4 		$2K Hold
97
– – ﹤0.01% 1275
2020
Q3 		$2K Hold
97
– – ﹤0.01% 1183
2020
Q2 		$2K Hold
97
– – ﹤0.01% 1130
2020
Q1 		$2K Sell
97
-97
-50% -$2.04K ﹤0.01% 1095
2019
Q4 		$5K Buy
194
+97
+100% +$2.36K ﹤0.01% 868
2019
Q3 		$3K Hold
97
– – ﹤0.01% 986
2019
Q2 		$3K Hold
97
– – ﹤0.01% 933
2019
Q1 		$3K Hold
97
– – ﹤0.01% 943
2018
Q4 		$3K Sell
97
-13
-12% -$559 ﹤0.01% 921
2018
Q3 		$6K Sell
110
-23
-17% -$1.14K ﹤0.01% 761
2018
Q2 		$8K Buy
133
+36
+37% +$1.86K ﹤0.01% 688
2018
Q1 		$4K Hold
97
– – ﹤0.01% 797
2017
Q4 		$4K Hold
97
– – ﹤0.01% 850
2017
Q3 		$4K Hold
97
– – ﹤0.01% 798
2017
Q2 		$4K Hold
97
– – ﹤0.01% 827
2017
Q1 		$3K Hold
97
– – ﹤0.01% 865
2016
Q4 		$2K Sell
97
-51
-34% -$1.14K ﹤0.01% 1049
2016
Q3 		$4K Buy
148
+51
+53% +$1.15K ﹤0.01% 806
2016
Q2 		$2K Hold
97
– – ﹤0.01% 964
2016
Q1 		$1K Buy
+97
New +$1.27K ﹤0.01% 1158

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCI Wealth Advisors's SUPN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q2 2023, closing a stake of 233 shares — an estimated $8.44K sold.

TCI Wealth Advisors first reported a position in SUPN in Q1 2016 and held it in 29 quarters. The position peaked at $8.44K in Q1 2023. 249 funds tracked by Wall St. Rank hold SUPN as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Supernus Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 233 Supernus Pharmaceuticals shares in Q2 2023, an estimated $8.44K.
  • TCI Wealth Advisors first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 29 quarters.
  • TCI Wealth Advisors's Supernus Pharmaceuticals position peaked at $8.44K in Q1 2023.
  • 249 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.